• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酯解抗体生化特性的差异与结构多样性相关。

Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.

作者信息

Zemel R, Schindler D G, Tawfik D S, Eshhar Z, Green B S

机构信息

Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Mol Immunol. 1994 Feb;31(2):127-37. doi: 10.1016/0161-5890(94)90085-x.

DOI:10.1016/0161-5890(94)90085-x
PMID:8309476
Abstract

A prerequisite to the design and engineering of catalytic antibodies is the knowledge of their structure and in particular which residues are involved in binding and catalysis. We compared the structure and catalytic properties of a series of six monoclonal antibodies which were all raised against a p-nitrophenyl (PNP) phosphonate and which catalyze the hydrolysis of p-nitrophenyl esters. Three of the antibodies (Group I) have similar light and heavy chain variable regions. The other three antibodies have similar VL regions of which two (Group II) have VH regions from the MOPC21 gene family and the remaining one (Group III) a VH from the MC101 gene family making a total of three different groups based on their V region sequences. The structural division into groups is paralleled by the differences in binding constants to hapten analogs, substrate specificity and the susceptibility of the catalytic activity of the antibodies to chemical modification of tryptophan and arginine residues. The relative binding of a transition state analog to the binding of substrate is much higher for the Group I antibodies than for the other groups. Only the Group I antibodies can catalyze the hydrolysis of a carbonate substrate. However all of the antibodies lose catalytic activity upon specific tyrosine modification which highlights the importance of tyrosine in the active site of the antibodies. Thus, antibodies raised against a single hapten can give antibodies with different structures, and correspondingly different specificities and catalytic properties.

摘要

催化抗体设计与工程的一个先决条件是了解其结构,尤其是哪些残基参与结合和催化作用。我们比较了一系列六种单克隆抗体的结构和催化特性,这些抗体均针对对硝基苯基(PNP)膦酸酯产生,并且催化对硝基苯酯的水解。其中三种抗体(第一组)具有相似的轻链和重链可变区。另外三种抗体具有相似的VL区,其中两种(第二组)具有来自MOPC21基因家族的VH区,其余一种(第三组)具有来自MC101基因家族的VH区,根据其V区序列总共分为三个不同的组。基于V区序列的分组与抗体对半抗原类似物的结合常数、底物特异性以及抗体催化活性对色氨酸和精氨酸残基化学修饰的敏感性差异相对应。第一组抗体中过渡态类似物与底物结合的相对亲和力比其他组高得多。只有第一组抗体能够催化碳酸酯底物的水解。然而,所有抗体在特定酪氨酸修饰后都会失去催化活性,这突出了酪氨酸在抗体活性位点中的重要性。因此,针对单一半抗原产生的抗体可以产生具有不同结构、相应地具有不同特异性和催化特性的抗体。

相似文献

1
Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.酯解抗体生化特性的差异与结构多样性相关。
Mol Immunol. 1994 Feb;31(2):127-37. doi: 10.1016/0161-5890(94)90085-x.
2
Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.源自一组催化抗体的重组单链Fv和Fv片段的表达与表征
Mol Immunol. 1997 Aug-Sep;34(12-13):891-906. doi: 10.1016/s0161-5890(97)00096-5.
3
A common ancestry for multiple catalytic antibodies generated against a single transition-state analog.针对单一过渡态类似物产生的多种催化抗体的共同祖先。
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6045-9. doi: 10.1073/pnas.91.13.6045.
4
Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.催化抗体家族中半抗原结合和催化决定因素的分析。
J Mol Biol. 1998 Jan 9;275(1):95-111. doi: 10.1006/jmbi.1997.1445.
5
Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.通过含有与抗原结合重链配对的混杂蛋白水解轻链的杂交抗体进行抗原特异性蛋白水解。
J Biol Chem. 2009 Sep 4;284(36):24622-33. doi: 10.1074/jbc.M109.011858. Epub 2009 Jun 19.
6
Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen.针对乙型肝炎病毒表面抗原的鼠源单克隆抗体免疫球蛋白可变区的分子特征及结构建模
Mol Immunol. 1993 Oct;30(14):1295-306. doi: 10.1016/0161-5890(93)90046-e.
7
Molecular analysis of multicatalytic monoclonal antibodies.多催化单克隆抗体的分子分析。
Mol Immunol. 2010 May;47(9):1747-56. doi: 10.1016/j.molimm.2010.02.024. Epub 2010 Mar 30.
8
A comparative analysis of the immunological evolution of antibody 28B4.抗体28B4免疫进化的比较分析
Biochemistry. 2001 Sep 11;40(36):10764-73. doi: 10.1021/bi010536c.
9
Primary structure and functional expression of heavy- and light-chain variable region genes of a monoclonal antibody specific for human fibrin.一种对人纤维蛋白具有特异性的单克隆抗体重链和轻链可变区基因的一级结构及功能表达
Hybridoma. 1997 Jun;16(3):235-41. doi: 10.1089/hyb.1997.16.235.
10
Amino acid sequences and hapten binding of catalytic and noncatalytic antibodies against N(alpha)-(5'-phosphopyridoxyl)-L-lysine.针对N(α)-(5'-磷酸吡哆醛)-L-赖氨酸的催化抗体和非催化抗体的氨基酸序列及半抗原结合情况
Mol Immunol. 2000 Aug;37(11):633-40. doi: 10.1016/s0161-5890(00)00090-0.

引用本文的文献

1
Binding specificity of hydrolytic catalytic antibody: lessons from the diverse immune system.水解催化抗体的结合特异性:来自多样化免疫系统的经验教训。
J Protein Chem. 1999 Feb;18(2):199-204. doi: 10.1023/a:1020680123291.
2
Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.铜绿假单胞菌O6血清型脂多糖特异性重组Fab片段的噬菌体展示及细菌表达
Clin Diagn Lab Immunol. 1997 Mar;4(2):147-55. doi: 10.1128/cdli.4.2.147-155.1997.
3
Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
催化抗体Fab片段与过渡态类似物复合物的晶体结构:酯酶样催化抗体中的结构相似性
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11721-5. doi: 10.1073/pnas.92.25.11721.
4
Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?用过渡态类似物免疫的MRL/lpr和SJL小鼠中催化抗体的意外高发生率:与自身免疫有联系吗?
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2145-9. doi: 10.1073/pnas.92.6.2145.
5
Catalytic antibodies: a critical assessment.催化抗体:批判性评估
Mol Biotechnol. 1994 Feb;1(1):87-103. doi: 10.1007/BF02821512.